Medtronic Altered Studies Regarding its InFuse Bone Graft Products
- Ennis & Ennis News
10/25/2012 - According to the United States Senate Finance Committee, executives of Medtronic, a medical device manufacturer, edited product studies, which had been performed by outside researchers to portray their product as superior to other competing products. Additionally, the Senate committee also noted that internal Medtronic documents showed that it inserted language into reports claiming that its InFuse product was superior to a bone graft as well. This fraudulent conduct came to light after the release of a report published in The Spine Journal, wherein a group of spine specialist publicly challenged the Medtronic studies claiming they had understated serious side effects associated with InFuse.
Further, the Senate Finance inquiry found that Medtronic had paid approximately $210 million dollars in fees, royalties and other payments to doctors participating in outside research on InFuse. InFuse treatments use a bioengineered protein matter that is then inserted into an LT-cage to stimulate bone growth after fusion surgery to alleviate back pain. Many critics of InFuse claim that Medtronic has always overplayed the benefits and downplayed the risks when marketing the InFuse products. The product was approved in 2002 for anterior lumbar approach fusion surgeries. Unfortunately, the product is used during off label surgeries nearly 85% of the time in procedures not approved by the Food and Drug Administration. These surgeries include multiple level lumbar surgeries performed posteriorly and the more dangerous use, insertion into the cervical spine.
Medtronic Infuse Bone Graft Lawyer Accepting Cases for Medtronic Infuse Bone Graft Lawsuit
If you or a loved one have been injured as a result of off label use of the Medtronic Infuse Bone Graft you may be entitled to compensation. Contact the Infuse Bone Graft Attorneys of Ennis & Ennis today for a free case evaluation. Our experienced Medtronic Infuse Bone Graft Lawyers can answer any questions you may have about a potential Medtronic Infuse Bone Graft Lawsuit. Call us toll free 1-800-856-6405 or fill out the form on this page for a FREE legal consultation.
Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies, as well as medical device makers.
Remember the law limits the time in which you can file a claim, so don't wait to explore your legal rights.